Image by Getty / FuturismThe active ingredient in Ozempic and Wegovy has once again proven to have health effects far outside of weight loss in a huge analysis linking it to lowered Alzheimer’s disease risk.Looking at more than a million patient records, researchers at Case Western Reserve School of Medicine discovered that diabetic seniors on semaglutide were far less likely to develop Alzheimer’s than their counterparts who took other diabetes medications.This effect was most stark when comparing semaglutide to the old-school diabetes injectable insulin, with patients on semaglutide showing a whopping…
